Amphastar Pharmaceuticals (AMPH) Gross Profit (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Gross Profit of $70.3 million for Q1 2026, down 17.51% year-over-year from $85.3 million in Q1 2025, and down 17.92% quarter-over-quarter from $85.7 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Gross Profit (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Gross Profit history runs 14 years deep, the most recent figure standing at $70.3 million for Q1 2026.
- In Q1 2026, Gross Profit fell 17.51% year-over-year to $70.3 million; the TTM figure through Mar 2026 stood at $341.1 million (down 7.55% YoY), while the FY2025 annual figure was $356.1 million, down 4.76% from the prior year.
- Gross Profit for Q1 2026 stood at $70.3 million, down from $85.7 million in the prior quarter.
- The five-year high for Gross Profit was $108.4 million in Q3 2023, with the low at $55.8 million in Q1 2022.
- The 5-year median for Gross Profit is $85.7 million (2025), against an average of $82.4 million.
- The sharpest annual moves came in 2023 and 2026: Gross Profit surged 85.27% in 2023, then dropped 17.51% in 2026.
- Amphastar Pharmaceuticals' Gross Profit stood at $71.2 million in 2022, then surged by 35.09% to $96.1 million in 2023, then retreated by 9.87% to $86.6 million in 2024, then decreased by 1.13% to $85.7 million in 2025, then retreated by 17.92% to $70.3 million in 2026.
- Business Quant data shows AMPH's Gross Profit at $70.3 million in Q1 2026, $85.7 million in Q4 2025, and $98.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Amphastar Pharmaceuticals | 937.04 Mn | 646.91 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.47 Mn |
| Jun 30, 2026 | 93.47 Mn |
| Mar 31, 2026 | 70.32 Mn |
| Mar 31, 2026 | 70.32 Mn |
| Dec 31, 2025 | 85.67 Mn |
| Dec 31, 2025 | 85.67 Mn |
| Sep 30, 2025 | 98.65 Mn |
| Sep 30, 2025 | 98.65 Mn |
| Jun 30, 2025 | 86.49 Mn |
| Jun 30, 2025 | 86.49 Mn |
| Mar 31, 2025 | 85.25 Mn |
| Mar 31, 2025 | 85.25 Mn |
| Dec 31, 2024 | 86.65 Mn |
| Dec 31, 2024 | 86.65 Mn |
| Sep 30, 2024 | 101.94 Mn |
| Sep 30, 2024 | 101.94 Mn |
| Jun 30, 2024 | 95.17 Mn |
| Jun 30, 2024 | 95.17 Mn |
| Mar 31, 2024 | 90.10 Mn |
| Mar 31, 2024 | 90.10 Mn |